Food and Drug Administration (FDA) and, after a recommendation from the European Medicines Agency (EMA), the European Commission issued emergency and conditional authorization for the Johnson & Johnson vaccine for individuals aged 18 years and older.
The vaccine has been approved for emergency use in 40 countries.Stay informed with live updates on the current COVID-19 outbreak and visit our coronavirus hub for more advice on prevention and treatment.However, the FDA recommended a pause in the vaccine’s use, as a precautionary measure following a small number of rare blood clot incidents.